TFM
RCUS icon

TFC Financial Management’s Arcus Biosciences RCUS Stock Holding History

TFC Financial Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Hold
1
– – ﹤0.01% 1013
2026
Q1 		$22 Hold
1
– – ﹤0.01% 988
2025
Q4 		$24 Hold
1
– – ﹤0.01% 957
2025
Q3 		$14 Buy
+1
New +$10 ﹤0.01% 993

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TFC Financial Management's RCUS Position: Q2 2026 in Review

TFC Financial Management held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 1 share worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

TFC Financial Management first reported a position in RCUS in Q3 2025 and has held it in 4 quarters since. 72 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • TFC Financial Management held 1 share of Arcus Biosciences worth $31 as of Q2 2026.
  • TFC Financial Management left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #1013 holding.
  • TFC Financial Management first reported a position in Arcus Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 72 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.